Tumor B7-H3 expression in diagnostic biopsy specimens and survival in patients with metastatic prostate cancer.

Gulanbar AmoriEmiko SugawaraYasuyuki ShigematsuMasashi AkiyaJunko KuniedaTakeshi YuasaShinya YamamotoJunji YoneseKengo TakeuchiKentaro Inamura

Published in: Prostate cancer and prostatic diseases (2021)

Tumor B7-H3 expression in diagnostic biopsy specimens may be a useful biomarker for identifying highly aggressive metastatic prostate cancer. Given the potential utility of anti-B7-H3 immunotherapy, this information may aid in stratifying prostate cancer based on its responsiveness to B7-H3-targeted treatment.

Keyphrases

prostate cancer
radical prostatectomy
fine needle aspiration
poor prognosis
ultrasound guided
squamous cell carcinoma
small cell lung cancer
risk assessment
cancer therapy
health information
combination therapy
social media
free survival